V-PLEX SARS-CoV-2 Panels

expired opportunity(Expired)
From: Federal Government(Federal)
RFQ-NIAID-2151276

Basic Details

started - 01 Dec, 2022 (16 months ago)

Start Date

01 Dec, 2022 (16 months ago)
due - 15 Dec, 2022 (16 months ago)

Due Date

15 Dec, 2022 (16 months ago)
Bid Notification

Type

Bid Notification
RFQ-NIAID-2151276

Identifier

RFQ-NIAID-2151276
HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Customer / Agency

HEALTH AND HUMAN SERVICES, DEPARTMENT OF (26850)NATIONAL INSTITUTES OF HEALTH (10866)NATIONAL INSTITUTES OF HEALTH NIAID (1804)
[object Object]

SetAside

SBA(Total Small Business Set-Aside (FAR 19.5))

Attachments (3)

unlockUnlock the best of InstantMarkets.

Please Sign In to see more out of InstantMarkets such as history, intelligent business alerts and many more.

Don't have an account yet? Create a free account now.

This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-2151276 and the solicitation is issued as a Request for Quotes (RFQ).This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2022-08 October 28, 2022.The North American Industry Classification System (NAICS) code for this procurement is 325413, In Vitro Diagnostic Substance,
with a size standard of 1250 employees. This requirement is being competed with a brand name restriction, and with a small business set-aside.This is for COVID-19 research.The Vaccine Immunology Program (VIP) of the National Institutes of Allergy and Infectious Diseases (NIAID) is seeking to procure Meso Scale Discovery kits. The V-PLEX SARS-CoV-2 Panel 19 (IgG) Kit (25 PL) and V-PLEX SARS-CoV-2 Panel 27 (IgG) Kit (25 PL) are needed for our studies to measure levels of antibodies against different SARS-CoV-2 variants. To assist in this effort, the VRC/VIP will use the electrochemiluminescence (ECL) assay format which they have recently developed for a SARS CoV-2 specific assay for the detection of specific antibodies directed towards SARS CoV-2 S-2P and RBD (or other stabilized version of this same protein), variants and subvariants (B.1.1.529, B.1.351, B.1.617)Manufacturer: Meso Scale DiscoveryProduct needed:1.   V-PLEX SARS-CoV-2 Panel 19 (IgG) Kit (25 PL), catalog # K15540U-4, quantity 62.   V-PLEX SARS-CoV-2 Panel 27 (IgG) Kit (25 PL), catalog # K15606U-4, quantity 1Delivery location:NIH/NIAID9 West Watkins Mill RoadGaithersburg, MD  20878Delivery Date: 30 Days ARO/expeditedPlace of Performance: NIH, VIP, 9 West Watkins Mill Road, Gaithersburg, MD  20878, United States.  * By submitting a quotation, you are accepting that all government terms and conditions set forth herein shall prevail over the award.The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein.  The award will be based on the following: technical capability to meet the requirements and price.The following FAR provisions apply to this acquisition: FAR 52.212-1 Instructions to Offerors Commercial Items (NOV 2021)FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (OCT 2022)FAR 52.204-7 System for Award Management (OCT 2018)(Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure FAR 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record)FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation (JAN 2017)FAR 52.204–26 Covered Telecommunications Equipment or Services-Representation(OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-26The following FAR contract clauses apply to this acquisition:FAR 52-212-4 Contract Terms and Conditions Commercial Items (NOV 2021)FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (OCT 2022)*The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (NOV 2021)FAR 52.204-13 System for Award Management Maintenance (OCT 2018)FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (NOV 2021)HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (DEC 2015)52.252-2 -- Clauses Incorporated by Reference. (FEB 1998)This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address:  http://farsite.hill.af.mil/vffara.htmBy submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax.Submission shall be received not later than Thursday, December 15, 2022, 2022 @ 12:00pm ESTOffers may be e-mailed to Rita Davis (E-Mail/ rita.davis@nih.gov). Offers shall include RFQ number in the subject line (RFQ-NIAID-2151276). Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f)All responsible sources may submit an offer that will be considered by this Agency. Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Rita Davis @ rita.davis@nih.gov.

Gaithersburg ,
 MD  20878  USALocation

Place Of Performance : N/A

Country : United StatesState : MarylandCity : North Potomac

You may also like

OVER THE COUNTER (OTC) COVID-19 TESTS

Due: 19 Mar, 2025 (in 10 months)Agency: OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE

EO14042 - VACCINE MANDATE FOR COVID19 INFO - KAPPA LAMBA AND HEVY LITE TESTING KITS

Due: 14 Jun, 2025 (in 13 months)Agency: VETERANS AFFAIRS, DEPARTMENT OF

OVER THE CONTER (OTC) COVID-19 TESTS

Due: 19 Mar, 2025 (in 10 months)Agency: OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE

Please Sign In to see more like these.

Don't have an account yet? Create a free account now.

Classification

naicsCode 325413In-Vitro Diagnostic Substance Manufacturing
pscCode 6640Laboratory Equipment and Supplies